What do systematic reviews say?

Summary of findings: unconditional cash transfer vs conditional cash transfers: primary outcomes

The review found no eligible studies for this question.

• Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health… 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings for cholinesterase inhibitors vs placebo

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 121 participants
  Very low

Summary of findings for cholinesterase inhibitors vs placebo

Summary of findings for cholinesterase inhibitors may leads to higher rate of adverse events excluding falls (per person year) compared with placebo (low certainty).

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  Rate ratio 1.6 [1.28, 2.01]
  2 studies · 175 participants
  Low

Summary of findings for cholinesterase inhibitors vs placebo

The review found no eligible studies for this question.

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings for cholinesterase inhibitors vs placebo

Summary of findings for cholinesterase inhibitors may leads to lower rate of falls (falls per person‐year) compared with placebo (low certainty).

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  Rate ratio 0.5 [0.44, 0.58]
  3 studies · 229 participants
  Low

Summary of findings for cholinesterase inhibitors vs placebo

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 230 participants
  Very low

Summary of findings for cholinesterase inhibitors vs placebo

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 23 participants
  Very low

Summary of findings: oral antioxidant combination vs control

The review found no eligible studies for this question.

• Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
• Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: oral antioxidant combination vs control

The review found no eligible studies for this question.

• Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: oral antioxidant combination vs control

The review found no eligible studies for this question.

• Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: oral antioxidant combination vs control

The review found no eligible studies for this question.

• Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: oral antioxidant combination vs control

The review found no eligible studies for this question.

• Antioxidant supplementation for lung disease in cystic fibrosis 2019 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Multifactorial interventions vs usual care

• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 3439 participants
  Very low
• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 44664 participants
  Low

Multifactorial interventions vs usual care

Summary of findings: Multifactorial interventions showed no clear difference in risk of falling Length of compared with usual care (low certainty).

• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  RR 0.92 [0.81, 1.05]
  9 studies · 3153 participants
  Low
• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  RR 0.82 [0.62, 1.09]
  3 studies · 39889 participants
  Very low

Multifactorial interventions vs usual care

It is very uncertain whether summary of findings: Multifactorial interventions changes risk of fracture Length of compared with usual care (very low certainty).

• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  RR 0.79 [0.3, 2.07]
  5 studies · 2160 participants
  Very low
• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  RR 0.76 [0.14, 4.1]
  2 studies · 4615 participants
  Very low

Multifactorial interventions vs usual care

• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 312 participants
  Very low
• Interventions for preventing falls in older people in care facilities and hospitals 2018 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 39763 participants
  Very low

Summary of findings table for oral immunoglobulin vs control

Summary of findings table for oral immunoglobulin showed no clear difference in definite necrotizing enterocolitis (NEC) during study period compared with control (low certainty).

• Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
  RR 0.84 [0.57, 1.25]
  3 studies · 1840 participants
  Low

Summary of findings table for oral immunoglobulin vs control

It is very uncertain whether summary of findings table for oral immunoglobulin changes definite necrotizing enterocolitis (NEC) during study period ‐ IgA/IgG compared with control (very low certainty).

• Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
  RR 0.08 [0, 1.39]
  1 study · 179 participants
  Very low

Summary of findings table for oral immunoglobulin vs control

Summary of findings table for oral immunoglobulin showed no clear difference in definite necrotizing enterocolitis (NEC) during study period ‐ IgG compared with control (low certainty).

• Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
  RR 0.95 [0.63, 1.42]
  2 studies · 1661 participants
  Low

Summary of findings table for oral immunoglobulin vs control

It is very uncertain whether summary of findings table for oral immunoglobulin changes definite NEC after study period compared with control (very low certainty).

• Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates 2016 · Cochrane Headline outcomes only
  RR 1.3 [0.47, 3.6]
  2 studies · 1661 participants
  Very low